Sanjivani Paranteral Ltd

Sanjivani Paranteral Ltd

₹ 202 1.13%
23 Jul 11:59 a.m.
About

Incorporated in 1994, Sanjivani Paranteral
Ltd does manufacturing and export of pharmaceutical products[1]

Key Points

Business Overview:
Sanjivani Paranteral Ltd is a pharmaceutical company headquartered in Mumbai. It specializes in manufacturing and distribution of high-quality parenteral and oral solid products. It caters to major therapeutic areas encompassing CNS, CVS, Antibiotics, Gastroenterological, Anti-Diabetics and Anti-Allergic, supported by a strong R&D set-up.[1]

  • Market Cap 236 Cr.
  • Current Price 202
  • High / Low 233 / 63.2
  • Stock P/E 38.3
  • Book Value 23.9
  • Dividend Yield 0.00 %
  • ROCE 55.3 %
  • ROE 49.7 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company is expected to give good quarter
  • Company has delivered good profit growth of 37.9% CAGR over last 5 years

Cons

  • Stock is trading at 8.48 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding has decreased over last quarter: -4.67%
  • Promoter holding is low: 27.7%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
7.20 8.08 9.72 7.60 5.21 9.92 8.33 9.12 8.12 12.58 14.00 14.96 12.86
5.74 7.32 8.40 5.65 3.52 7.77 7.20 8.20 6.69 10.57 11.88 12.99 10.70
Operating Profit 1.46 0.76 1.32 1.95 1.69 2.15 1.13 0.92 1.43 2.01 2.12 1.97 2.16
OPM % 20.28% 9.41% 13.58% 25.66% 32.44% 21.67% 13.57% 10.09% 17.61% 15.98% 15.14% 13.17% 16.80%
0.18 0.07 0.08 0.03 0.06 0.12 0.17 0.31 -0.04 0.06 0.15 0.25 0.05
Interest 0.03 0.03 0.04 0.06 0.08 0.07 0.07 0.05 0.16 0.04 0.05 0.08 0.09
Depreciation 0.23 0.18 0.25 0.22 0.23 0.22 0.22 0.23 0.23 0.23 0.23 0.24 0.24
Profit before tax 1.38 0.62 1.11 1.70 1.44 1.98 1.01 0.95 1.00 1.80 1.99 1.90 1.88
Tax % -0.72% 0.00% 0.00% 0.00% 2.08% 9.60% 23.76% 0.00% 0.00% 13.89% 14.07% 13.16% 33.51%
1.39 0.63 1.11 1.70 1.41 1.80 0.77 0.95 1.00 1.55 1.71 1.65 1.26
EPS in Rs 1.64 0.74 1.11 1.70 1.41 1.80 0.77 0.95 1.00 1.55 1.71 1.65 1.08
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
151.70 158.50 133.03 115.31 32.53 17.96 25.09 16.29 25.09 30.59 41.45 54.41
141.11 148.93 127.71 120.84 55.81 70.17 26.85 16.62 22.95 24.86 35.80 46.18
Operating Profit 10.59 9.57 5.32 -5.53 -23.28 -52.21 -1.76 -0.33 2.14 5.73 5.65 8.23
OPM % 6.98% 6.04% 4.00% -4.80% -71.56% -290.70% -7.01% -2.03% 8.53% 18.73% 13.63% 15.13%
2.12 2.51 1.24 0.73 2.85 0.48 0.96 0.25 0.26 0.24 0.54 0.52
Interest 7.93 8.09 7.92 8.81 4.79 0.45 0.33 0.66 0.13 0.21 0.36 0.25
Depreciation 0.99 0.95 1.41 1.36 1.20 1.19 1.17 1.07 0.86 0.88 0.89 0.93
Profit before tax 3.79 3.04 -2.77 -14.97 -26.42 -53.37 -2.30 -1.81 1.41 4.88 4.94 7.57
Tax % 36.15% 47.37% -13.00% -2.20% -0.72% -0.60% -10.00% -5.52% -0.71% 0.61% 8.70% 18.63%
2.43 1.59 -2.41 -14.64 -26.22 -53.06 -2.07 -1.71 1.42 4.85 4.51 6.17
EPS in Rs 4.12 2.70 -4.09 -24.82 -44.45 -89.96 -3.51 -2.90 1.67 4.85 4.51 5.28
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: -10%
5 Years: 17%
3 Years: 29%
TTM: 31%
Compounded Profit Growth
10 Years: 15%
5 Years: 38%
3 Years: 63%
TTM: 37%
Stock Price CAGR
10 Years: 26%
5 Years: 89%
3 Years: 90%
1 Year: 202%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 50%

Balance Sheet

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 5.90 5.90 5.90 5.90 5.90 5.90 5.90 5.90 8.50 10.00 10.00 11.68
Reserves 27.52 29.11 26.24 11.60 -14.62 -58.72 -53.10 -54.81 -53.39 -17.58 -13.07 16.21
57.39 56.90 57.06 62.20 59.89 48.23 48.09 48.91 46.05 6.00 2.49 0.97
22.35 25.46 24.48 13.42 9.15 29.61 17.09 15.66 18.11 19.87 21.59 14.55
Total Liabilities 113.16 117.37 113.68 93.12 60.32 25.02 17.98 15.66 19.27 18.29 21.01 43.41
23.86 24.24 13.52 12.69 11.19 10.17 8.99 8.04 7.62 7.42 7.57 9.94
CWIP 0.07 0.07 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.00
89.18 93.01 100.10 80.38 49.08 14.80 8.94 7.57 11.60 10.82 13.39 33.47
Total Assets 113.16 117.37 113.68 93.12 60.32 25.02 17.98 15.66 19.27 18.29 21.01 43.41

Cash Flows

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
7.36 8.77 -1.20 0.45 9.57 3.05 2.48 -0.17 0.58 8.52 4.68 -10.70
-1.20 -1.32 8.68 -0.50 0.30 -0.20 0.02 -0.12 -0.42 -0.67 -0.99 -12.21
-5.97 -7.57 -7.30 -0.51 -10.05 -2.83 -2.30 0.33 -0.26 -7.68 -3.73 23.16
Net Cash Flow 0.19 -0.12 0.18 -0.57 -0.18 0.03 0.20 0.03 -0.09 0.17 -0.04 0.24

Ratios

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 142.01 149.34 184.24 151.59 358.38 107.71 75.79 23.97 96.45 58.71 17.52 31.53
Inventory Days 50.08 54.73 68.59 65.35 127.41 34.08 13.56 66.80 22.43 51.89 105.21 124.70
Days Payable 43.74 48.78 37.50 19.51 42.51 169.13 292.82 434.62 261.00 339.20 269.82 73.56
Cash Conversion Cycle 148.35 155.29 215.34 197.43 443.28 -27.33 -203.47 -343.84 -142.12 -228.61 -147.08 82.67
Working Capital Days 150.50 144.80 198.43 180.87 368.14 -460.72 -181.99 -342.37 -174.86 -134.24 -114.03 35.55
ROCE % 13.02% 12.18% 5.95% -7.31% -35.52% -227.18% -258.43% 265.52% 55.28%

Shareholding Pattern

Numbers in percentages

Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
19.85% 27.35% 27.35% 27.35% 27.35% 27.35% 29.88% 31.70% 32.34% 32.34% 27.67% 27.67%
16.50% 16.50% 16.50% 16.50% 16.50% 16.50% 14.23% 11.89% 8.16% 6.01% 9.71% 9.36%
63.65% 56.14% 56.14% 56.14% 56.14% 56.14% 55.89% 56.40% 59.51% 61.65% 62.62% 62.98%
No. of Shareholders 4,8295,0044,9744,8484,8264,8454,8874,7584,5004,5004,9116,166

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls